CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business ...
CALGARY, AB - March 16, 2026 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (OTC Pink: VYYRF) (the "Company" or "Voyageur"), a pharmaceutical company focused on developing barium and ...
Enables GE Healthcare to secure increasing supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) imaging procedures Supports GE Healthcare’s broader ...
Calgary, Canada – TheNewswire – August 25, 2025 - Voyageur Pharmaceuticals Ltd. (VM:CA) (OTC: VYYRF) ("Voyageur" or the "Corporation") is pleased to announce the launch of its U.S.-based iodine ...
The global iodinated contrast media market is anticipated to register a steady growth rate of around 6% over the next five years, driven by the increasing reliance on advanced diagnostic imaging ...